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ocular cicatricial pemphigoid is a rare vesiculobullous dis-
ase characterized by linear deposition of IgG and/or IgA ~long the basem~nt mel:nbrane z.one of conjunctival biops.ies. 
This study identifies a tissue antigen detected by ocular cica-
tricial pemphigoid patient se·ra. 
Patient selection was based on the presence of only ocular 
involvement and a positive dir.ect immunofluorescence. of 
conjunctiva. We evaluated patient and control sera usmg 
. direct immunofluorescence of basement membrane zone l~parated skin, Western blot, and purified antibodies from ~itrocellulose and epidermal sheets. 
Direct immunofluorescence performed on the patients' 
conjunctival biopsy showed linear deposition of IgA along 
he basement membrane zone in all seven patients, and five of 
t even also demonstrated deposition of IgG along the base-~ent membrane zone. Indirect immunofluorescence per-
formed on the patients' sera demonstrated linear deposition 
of IgA along the epidermal side of the basement membrane 
one of ethylenediaminetetraacetic acid - separated skin in all ~even patients. IgA titers ranged from 1 : 20 to 1 : 80. No IgG 
C icatricial pemphigoid (CP) is a chronic subepidermal, autoimmune, vesiculobuJlous disease that primarily affects mucosal surfaces [1-3]. Linear deposition of IgG and/or IgA along the basement membrane zone (BMZ) is characteristic of CP, but very little infor-
mation is available concerning the antigen responsible for antibody 
binding in CPo 
Traditionally , serum of patients with CP has rarely been shown 
to demonstrate the presence of circulating antibodies th~t bind to 
the BMZ using indirect immunofluorescence (UF) techl1lques [4-
11]. These studies were done with a v.ariery of substrates and pre-
dom.inantly searched for IgG-class antibodies. 
Antigenic proteins extracted from the skin have been demon-
strated in bullous pemphigoid (BP) [12,13]' epidermolysis bullosa 
acquisita [14], pemphigus vulgaris [15], pemphigus foliaceous [1 6]. 
and herpes gestation is [17], but the antigen responsible for antibody 
binding in CP is still controversial. Direct iml11unoelectron micro-
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was detected. Immunoblots detected IgA binding to a 4S-kD 
antigen in all patients as well as sporadic IgA binding to a 
number of other proteins. Immunoblots stained with sera 
from patients did not show reactivity to the 230- or 180-kD 
bullous pemphigoid antigens or the 97 -kD linear IgA bullous 
dermatosis antigen. Eluting IgA from the 4S-kD region and 
other regions revealed that only antibodies eluted from the 
4S-kilodalton region bound linearly to the basement mem-
brane on separated skin. Purification of IgA using epidermal 
sheets confirmed that the antibody responsible for staining 
on indirect immunofluorescence bound to the 45-kD region 
on Western blot. Sera from normals and patients with bul-
lous pemphigoid, dermatitis herpetiform is, and linear IgA 
bullous dermatosis fai led to demonstrate basement mem-
brane zone IgA on elution of the 45-kD region. 
We conclude that these ocular cicatricial pemphigoid sera 
contain a unique IgA antibody that binds to a 45-kD base-
ment membrane zone antigen. Key words: bullous disease/ 
autoimmune/Western Blot/purification. ] Ir~vest Dermatol 
101:619-623, 1993 
scopy studies of patients with CP reveal localization of the inU11uno-
reactants within the lamina lucida of the BMZ [18,19]. Despite 
localization of immunoreactants within the lamina lucida, studies 
have shown that the antigen involved in CP may be distinct from 
the BP antigen [18,20 - 22] . On the other hand, Bernard el 01 and 
Niimi et 01 reported identification of a CP antigen that is similar to 
the bullous pemphigoid antigen [23,24]. 
In the present study we emolled seven patients with clinical evi-
dence of ocular cicatricial pemphigoid (OCP). In all seven patient 
sera we identified IgA antibodies using BMZ-separated skin and we 
identified a 45-kD BMZ antigen that binds IgA antibodies. The 
antigen was identified in epidermal extracts using Western blots. 
BMZ specificity was confirmed using immunoaffinity-purified an-
tibodies. 
MATERIALS AND METHODS 
Patient ~election Seven patients meeting the following criteria were 
enrolled 111 our study: clinical evidence of ocular disease (excluding those 
with ora~ and skin disease) and a positive conjunctival biopsy for IgG and/ or 
IgA. Pattents with a negative direct immunofluorescence (DIF) were ex-
cluded fr0111 the study. 
Sera Seven OCP sera meeting the above criteria were evaluated. Controls 
included five BP, four dermatitis herpetiformis, two linear IgA bullous 
dermatosis patients, and eight normal controls free from bullous disease. 
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Separated Skin Skin separated at the BMZ has been shown to be a good 
substrate for lIF testing [1 8,25 - 28J. Various methods have been developed 
for separation of epidermis from the dermis using sodium chloride or ethy-
lenediaminete traacetic acid (EDTA) [18,26 - 28). EDT A-separated skin was 
used in our lIF techniques and was prepared as previously described by Meyer 
et al [27). 
Immunofluorescence DIF testing was performed on all conjunctival 
biopsies following standard techniques [27 - 29). T1F testing was performed 
on all se ra for IgG and IgA (Cappel Laboratories, Malvern, PAl following 
the standard lIF technique [27 - 29). 
Epidermal Extracts Epidermis used for polyacry lamide gel electrophore-
sis was separated from dermis at the BMZ by heating at 56·C and extracts 
were made from the epidermis as described previously [30]. The epidermal 
extract was stored at -70· C. There was no loss or change in antigeniciry 
with storage. 
Electrophoresis and Western Blots Polyacrylamide gel electrophores is 
was performed using epidermal extracts by the method of Laemmli [31], 
with use of a 9.5% acrylamide running gel and 5% acrylamide stacking ge l. 
Following polyacrylamide gel electrophoresis, proteins were transferred 
electrophorectically onto nitrocellulose, as described by Towbin et al [32]. 
Strips of nitrocellulose were incubated with all sera at a 1: 10 dilution, then 
with biotinylated goat anti-human IgA, and were finally incubated in an 
av idin-biotin-peroxidase complex. Protein bands were stained with 4-chlor-
onaphthol and hydrogen peroxide (H20 2) [33]. 
Western Blot Immunoaffinity Protein bands on Western blots from 
Laemmli gels were used as immunoaflinity substrates for purification of 
antibod ies directed against specific proteins in the epidermal extract as de-
scribed by Olmsted [34) and modified by Smith and Fisher [35). Briefly, 
vertical strips were cut from the end of nitrocellulose containing the antigen 
in question and incubated with sera containing the antigen-specific anti-
body. A second incubation with goat anti-human IgA and, finally, an avid in-
biotin-peroxidase complex , was incubated with the antigen-specific anti-
body. The protein bands were stained with 4-chloronaphthol and H20 2 for 
identifica tion of the bands ofinterest [33). Horizontal strips of nitrocellulose 
containing the antigen of interest were cut using the end strips as a template 
and incubated with a 1: 5 dillltion of sera for 2 h. The antibody was eluted 
from the horizontal strips using 20 mM sodium citrate, pH 3.2. The eluent 
was then neutralized with 2 M tris buffer, pH 8, and stored at 4 · C until used 
in our W estern blot and IIF techniques. A slight modification of the lIF 
technique was used to detect eluted antibodies. Incubation time was 
increased to 4 h to assure binding of the eluted antibody and increased 
sensitiviry. 
Basement Membrane Zone Immunoaffinity EDT A-separated skin 
was used as an immunoaffinity substrate for purification of anti-BMZ anti-
bodies as desc ribed previously [28). Briefly, abdominoplasty skin was incu-
bated overnight at 4 · C in 20 mM EDTA. The epidermis was removed from 
the dermis and placed in a humidifying chamber with the DMZ up. A 1: 7 
di lution of serum was incubated with the epidermal sheet for 2 h at room 
temperature. The antibod ies were then eluted from the epidermal sheet with 
20 mM sodium citrate, pH 3.2. The eluates were neutralized with 2 M tris 
pH 7.5 and stored at 4·C until used for IIF and Western blot techniques. 
RESULTS 
Immunofluorescence Studies DIF performed on the patients' 
conjunctiva l biopsy showed linear deposition ofIgA along the BMZ 
in all seven patie nts, and five of seven also demonstrated deposition 
of IgG along the BMZ. I1F performed on the patients' sera demon-
strated linear deposition oflgA along the epidermal side of the BMZ 
of EDT A-separated skin in all seven patients (Fig 1). There was no 
dermal binding of antibody . IgA t iters ranged from 1: 20 to 1 : BO. 
There was no detectable IgG. Normal control sera failed to demon-
strate basement membrane zone antibody. ' 
Immunoblot Epidermal Extracts Immunoblots stained with 
these low-titer OCP sera demonstrated binding ofIgA to numerous 
proteins (Fig 2). It was not apparent from Western blot alone 
which , if any, of the antibodies bound on Western blot w e re re-
sponsible for the BMZ binding seen on IIF. To determine which 
band was responsible for the linear staining of the BMZ seen on the 
lIF W estern blot, immunoaffinity purification was performed . Ini-
tially each protein band seen on Western blot from the serum of 
patient 2 (Fig 2, lane 2) was eluted from nitrocellulose. The only IgA 
antibody to bind to the BMZ in a linear fashion was from a band in 
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Figure 1. Indirect immunofluorescence. IIF of OCP sera showing linear 
deposition of! gA along the epidermal side of the BMZ. Skin separated at the 
BMZ with 20 mM EDT A was used as substrate. 
the 4S-kD region (Fig 3) . Immunoaffinity-purified antibodies from 
the other reg ions of the immunoblot from patient 2 did not bind to 
the BMZ. Subsequently antibody fro m the 4S-kD reg ion was e luted 
from all OCP patients ' sera and BMZ reactivity was confirmed in all 
se ra . It was not feasibl e to elute all bands from all patients, but 
basement membrane zone immunoaffinity purification was used to 
further verify the importance of the 4S- kD band. 
lmmunoblots stained with OCP sera using epidermal extracts 
containing the 230-kD, 1BO-kD BP antigens (Fig 4) or the 97-kD 
antigen (not shown) did not show reactivity at those molecular 
weight regions. (See Table I). Iml1lunoblots stained with control 
sera using epiderma l extracts and serum diluted 1 : 10 sh owed non-
specific reactivity with IgA class antibodies in the 4S-kD region. 
This included each of the five BP, four dermatitis herpetiformis, 
two linear IgA bullolls dermatosis sera, and two of the eight normal 
se ra (not shown) . However, w hen antibodies from control sera that 
bound to this region were eluted from nitrocellulose and used in our 
IlF procedure they did not bind back to the BMZ. Immunoblots 
stained with sera used at low dilutions (1: 10) frequently produce 
---OCP'--- -NI- NolO 
12345678910 
Figure 2. Immunoblot. Western blot using epidermal extract rich in 45-
kD antigen and incubated with OCP and normal sera. Lalles 1- 7, OCP sera; 
lalles 8 alld 9, normal control sera; and lalle 10, no primary control, which is 
not incubated with serum. Nitrocellulose was incubated with biotinylated 
goat anti-human IgA . 
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Fi ure 3. Indirect immunofluorescence. IIF of ocp immunoaffinity-pur-
ifi;d antibody showing linear deposition of IgA along the BMZ on the 
epidermal side. Skm separated at the DMZ with 20 rnM EDTA was used as 
substrate. 
IgA binding in the 40-60-kD region. When many of these anti-
bodies are eluted, binding to various antigens within the epidermis 
occurs. We believe this to represent non-specific keratin binding. In 
contrast, when the IgA antibodies from OCP sera were eluted from 
nitrocellulose, they specifically bound to the BMZ of separated skin 
in a linear fashion and the eluted antibody also bound back to the 
4S-kD region on immunoblot. 
BaseJnent Membrane Zone Immunoaffinity Immunoblots 
(as described above) were used as immunoaffin.ity substrates to de-
termine whether the antigen detected on Immunoblot corre-
sponded with the antigen detected by . immun?fluorescence .. To 
further support the Idea that the circulatlllg IgA 111 OCP sera blllds 
to this newly described 4S-kD BMZ antigen, we used epidermal 
sheets to purify the BMZ-binding IgA antibodies. These purified 
antibodies were then compared to whole sera of the same patIents. 
In all cases there was binding of the BMZ-purified antibody to the 
97-1 
66-
Figure 4. Immunoblot. Western blot using epidermal extract rich in 180-
and 230-kD BP antigens were incubated with OCP and normal sera. Latlcs 1 
and 2, BP sera known to contain the 180- and 230-kD antigens, respectively. 
LAnes 3 - 7, OCP sera; lalles 8 mId 9, normal control sera. DP control strips 
were incubated with biotinylated goat anti-human IgG and OCP and nor-
mal control strips were incubated with biotinylated goat anti-human IgA. 
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Table I. Summary of Indirect Immunofluorescence and 
Western Blot Analyses of OCP Patient Sera 
Western Blot 
Serum Titer, Western Blot {97-, 180- and 
Patient 
Separated Skin" (45-kD Antigen) 230-kD Antigen) 
Number IgA IgG Epidermal Extractb Epidermal Extract" 
1 1:80 Negative Positive Negative 
2 1 :80 Negative Positive Negative 
3 1 :80 Negative Positive Negative 
4 1:80 Negative Positive Negative 
5 1:40 Negative Positive Negative 
6 1 :40 Negative Positive Negative 
7 1 :20 Negative Positive Negative 
• Evaluation of serum IgA-class antibasement membrane antibody titer by IIF using 
20. mM EDTA-separated skin as substrate. Reported as las t titer showing staining of the 
epIdermal SIde of 20. mM EDT A-separated skin. 
b Western blot of epidermal extracts rich in BMZ antigens incubated with patient 
serum diluted 1 : 10. and biotinylated goat anti-human IgA or IgG. 
45-kD region (Fig 5), demonstrating that the antibody eluted from 
the BMZ binds to an epidermal antigen in the 45-kD region. 
The data produced using the various techniques on all OCP sera 
are summarized in Tables I and II. 
DISCUSSION 
CP is a rare vesiculobullous disease resulting in separation of the 
basement membrane between the epithelium and underlying 
stroma [1-3] . Because immune deposits of IgA and IgG as well as 
complement have been shown to be deposited at the BMZ by DIF 
and some patients have circulating antibodies in their serum that 
bind to the BMZ, it is likely that immunologic mechanisms are 
involved in the pathogenesis of the disease. 
In this study, serum from seven patients with OCP contained IgA 
antibodies that bound to the BMZ of normal human skin, as dem-
onstrated by lIF. Our seven OCP patients had disease limited to 
their eyes and BMZ IgA autoantibodies in their serum. The IgA 
autoantibodies all bound to the epidermal side of skin that had 
1 2 3 4 
201-
97-
6·6- ' 
l I 
Figure 5. Immul1oblot. Western blot using epidermal extract rich in the 
45-kD antigen were incubated with OCP sera and DMZ-purified antibodies. 
Latle 1, molecular weight standards; lall e 2, OCP sera; latle 3, BMZ-purified 
antibody from the serum shown in lane 2; lalle 4, no primary control , which 
is not incubated with serum. Nitrocellulose was incubated with biotinylated 
goat anti-human IgA. 
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Table II. Summary of Immunoaffinity-Purified Antibodies' 
Nitrocellulose- Epidermal Sheet-
Eluted Antibody Eluted Antibody 
Patient Separated Epidermal Separated Epidermal 
Number Skin Extract Skin Extract 
1 Positive Positive Positive Positive 
2 Positive Positive Positive Positive 
3 Positive Positive Positive Positive 
4 Positive Positive NO NO 
5 Positive Positive NO NO 
6 Positive Positive NO NO 
7 Positive Positive NO NO 
• Nitrocellulose and epidermal sheets were used as immunoaffinity substrates for 
purification of the IgA-antigen -specific antibody from OCP sera. These purified anti-
bodies were used to probe epidermal extracts and BMZ-separated skin for reactivity 
with the 45-kD antigen. NO, not done . 
previously been separated through the BMZ. Furthermore, we have 
shown that the target antigen for IgA autoantibodies in the serum of 
our patients with OCP is a 45-kD protein. All seven patients recog-
nized this 45-kD protein on W estern blots of epidermal extracts. 
Eluting IgA from the 45-kD region and other regions revealed that 
only antibodies eluted from the 45-kD region bound linearly to the 
BMZ on separated skin. Purification of IgA using epidermal sheets 
confirmed that the antibody responsible for staining on IIF bound to 
the 45-kD region on W estern blot. Sera from normals and patients 
with BP, dermatitis herpetiformis, and linear IgA bullous dermato-
sis fai led to demonstrate basement membrane zone IgA on elution 
of the 45-kD region. 
Several studies have shown that sera from CP patients have circu-
lating IgG and/or IgA antibodies that bind the BMZ by IIF [4-11] . 
These studies were performed using a variety of substrates and pre-
dominantly searched for IgG-class antibodies. Perhaps our success 
in identification of IgA-class circulating antibodies may be due to 
the patient population selected and the substrate used for IlF. Our 
patient population was limited to CP patients with only eye disease. 
The other studies included CP patients with buccal mucosal in-
vo lvement and many even had cutaneous involvement. Many of the 
studies did not look for or were unable to find IgA-class circulating 
antibodies. Identification of circulating antibodies has been difficult 
in the past but it has been shown that skin separated at the BMZ is a 
good substrate for IIF testing [1 8,25-28]. In a recent cooperative 
study, Sarret et al [36] evaluated sera of 11 patients with CP, which 
demonstrated positive IIF using normal human skin separated at the 
BMZ and that circulating IgA antibody was the single immuno-
globulin class in 55% of the sera. Our study has confirmed that IgA 
is the predominant immunoglobulin class present in OCP serum 
and that BMZ split skin is a good substrate for demonstrating the 
presence of circulating antibodies. Further support for the potential 
role ofIgA includes: 1) th e fact that IgA is the predominant mucosal 
immunoglobulin and is likely to be important in the pathogenesis of 
mucosal immune disorders such as CP, and 2) dapsone, which has 
been shown to be effective in treating IgA dermatoses, has also been 
shown to be effective in the treatment of CP [37]. 
For many years, there has been controversy regarding th e nature 
of the antigen(s) that react with autoantibodies in CP. Initial reports 
of the isolation of antigens with molecular weights ranging from 90 
to 280 kD that predominantly bound IgG have not been confirmed 
[21-24]. Two reports from Bernard et al and Niimi et al have de-
scribed IgG antibodies reactive with antigens similar to the 230-kD 
and 180-kD ofBP [23,24]. We describe a 45-kD BMZ antigen that 
binds circulating IgA from our select group of CP patients. What 
role this antigen plays in the pathogenesis of CP is yet to be deter-
mined. We believe that this antigen may be a component of a larger 
molecular weight protein and identification of this larger molecular 
weight protein may be impossible by W estern blot. The methodol-
ogy used in immunoblotting is substantially different from that 
employed in immunoprecipitation; the substrate is epidermal sheets 
THE J O URNA L OF INVESTIGATIVE DERMATOLOGY 
from su~gical procedures, and the tissue is homogenized directly 
111to sodIUm dodecyl sul fate (SDS) and reduced. The denaturing 
effect of the SDS renders this technique less sensitive than immuno-
precipitation, and reduction may produce antigenically inactive 
proteins. Our future goal will be to perform immunoprecipitation 
with these sera to determine whether the 45-kD protein is actually a 
component of a larger molecular weight protein. 
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